Erin C. Sanders

Erin C. Sanders

Auto-generated profile, based on publicly available information

Erin C. Sanders

Institute for Stem Cell Biology and Regenerative Medicine and the Ludwig Cancer Center, Stanford University School of Medicine, Stanford, CA, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

30 August 2021 in medRxiv
Verified
Preprint
Open access
PDF file
GNGeorge Ronald Nahass
George Ronald Nahass
RSRachel E. Salomon-Shulman
Rachel E. Salomon-Shulman
GBGrace Blacker
Grace Blacker
KHKazim Haider
Kazim Haider
RBRich Brotherton
Rich Brotherton
MTMichal Caspi Tal
Michal Caspi Tal
Vaccination induced antibody and T-cell immune responses are important for systemic protection from COVID-19. Because SARS-CoV-2 infects and is transmitted by oral-pharyngeal mucosa, we wished to test mucosal antibodies elicited by natural infection or intramuscular vaccine injection. In a non-randomized observational study, we measured antibodies against the SARS-CoV-2 RBD in plasma and saliva from convalescent or vaccinated individuals and tested their neutralizing potential using a replication competent rVSV-eGFP-SARS-CoV-2. We found IgG and IgA anti-RBD antibodies as well as neutralizing activity in convalescent plasma and saliva. Two doses of mRNA vaccination (BNT162b2 or mRNA-1273) induced high levels of IgG anti-RBD in saliva, a subset of whom also had IgA, and significant neutralizing activity. We detected anti-RBD IgG and IgA with significant neutralizing potential in the plasma of single dose Ad26.COV2.S vaccinated individuals, and we detected slight amounts of anti-RBD antibodies in matched saliva. The role of salivary antibodies in protection against SARS-CoV-2 infection is unknown and merits further investigation. This study was not designed to, nor did it study the full kinetics of the antibody response or protection from infection, nor did it address variants of SARS-CoV-2.

29 May 2020 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
ABAbdul Baig
Abdul Baig
ESErin C. Sanders
Erin C. Sanders